LONDON, UK / ACCESSWIRE / August 19, 2020 / World High Life Plc (AQSE:LIFE)(OTCQB:WRHLF) is pleased to announce that its wholly owned subsidiary, London-based CBD brand, Love Hemp Limited ("Love Hemp") reports a 57% growth in sales in July 2020 over June 2020.

"The wellness industry isn't showing any signs of slowing down. What we have witnessed is an increased consumption of CBD during the pandemic, and we expect this to continue post-Covid. We believe that people who continue to feel anxious or have trouble sleeping and are increasingly turning to more natural health and wellness solutions to add to their self-care routines," says Tony Calamita, CEO at Love Hemp.

Love Hemp Growth Highlights

57% increase in sales in July 2020 across online, retail and wholesale compared to June 2020
Online sales remain significantly higher than pre-Covid levels, with this channel making up 62% of sales in July 2020 compared with 40% of sales in January 2020
Continued growth highlights the success of the brand strategy, with Love Hemp focused on building an accessible and supportive brand that is destigmatising CBD consumption while demystifying CBD in the UK

"As the government takes steps to stimulate the economy and lift consumer sentiment, we are seeing a welcome boost for physical store sales. At the same time, our online sales remain well above pre-pandemic levels, cementing the importance of our eCommerce strategy in underpinning brand experience," adds Mr. Calamita.

For further information please contact:

David Stadnyk
Founder & CEO
North America: 1 (236) 521-7211
North America toll-free: 1 (888) 616-WRHLF (9745)
+44 (0) 7926 397 675
info@worldhighlife.uk

AQSE Corporate Adviser
Mark Anwyl/Allie Feuerlein
Peterhouse Capital Limited
+44 (0) 20 7469 0930
ma@peterhousecap.com
af@peterhousecap.com

Financial PR
Camilla Horsfall/Megan Ray
Blytheweigh
+44 (0) 20 7138 3224
Camilla.horsfall@blytheweigh.com
Megan.Ray@blytheweigh.com

For more information on World High Life please visit: www.worldhighlife.uk

Market Abuse Regulation (MAR) Disclosure
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Cautionary Note Regarding Forward Looking Information
We seek safe harbour. Some statements contained in this news release are "forward looking information" within the meaning of securities laws. Forward looking information include, but are not limited to, statements regarding the use of proceeds of the non-brokered private placement and payment of the debt settlements. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", "believes" or variations of such words and phrases (including negative or grammatical variations) or statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved" or the negative connotation thereof. Investors are cautioned that forward-looking information is inherently uncertain and involves risks, assumptions and uncertainties that could cause actual results to differ materially. There can be no assurance that future developments affecting the Company will be those anticipated by management. The forward-looking information contained in this press release constitutes management's current estimates, as of the date of this press release, with respect to the matters covered thereby. We expect that these estimates will change as new information is received. We do not undertake to update any estimate at any particular time or in response to any particular event, except as required by law.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: World High Life PLC

ReleaseID: 602332

VANCOUVER, BC / ACCESSWIRE / August 19, 2020 / Makara Mining Corp. (CSE:MAKA)(FSE:MK0)(OTC PINK:MAKAF) ("Makara" or the "Company") is pleased to announce that it has acquired the right (the "Option") to earn 100% of the Idaho Creek Property ("Idaho" or the "Idaho Property"), which borders the Company's existing Rude Creek Gold Project ("Rude Creek" or the "Rude Creek Property") in the White Gold region of the Yukon, Canada, from ATAC Resources Ltd (the "Optionor" or "ATAC").

Once earned, the Idaho Property will extend Makara's northern coverage of the prospective geology at its Rude Creek Property by 6 km. The Idaho Property east-west width (6 km) is similar to that of the Rude Creek property (being 7 km). The Idaho Property currently covers 1218 hectares (with potential for expansion up to 1848 hectares) and the Rude Creek Property covers 4157 hectares, for a total land package totalling up to 6005 hectares. Makara is excited to add to its Rude Creek Property through the Option, in that any mineralization discovered on the Rude Creek Property could stretch into the Idaho Property. Through the Option, Makara's land position has increased significantly and our new northern boundary will be directly adjacent to White Gold's large land position in the area with no intervening land.

About the Option

Pursuant to the Option, Makara holds the right to acquire 100% of the Idaho Property by: (i) paying ATAC an aggregate of $150,000 over a four-year period; (ii) issuing ATAC an aggregate of 750,000 common shares over a four-year period (the "Share Consideration"); and (iii) incurring aggregate exploration expenditures at the Idaho Property of $2,000,000 over a four-year period. Upon Makara exercising the Option, ATAC shall be entitled to (i) a 2% NSR royalty, half of which can be purchased by Makara for $1,000,000 and (ii) a one-time discovery fee of $1 for each ounce of gold identified in the earlier of a NI 43-101-compliant (A) measured and indicated resource estimate applicable to the Idaho Property or (B) proven or probable reserve estimate applicable to the Idaho Property, which may be paid out over one (1) year. Any Share Consideration issued to ATAC will be subject to restrictions on resale for a period of six (6) months from the date of issuance.

Idaho Creek Geology

The Idaho Property has very similar geology to Rude Creek. The Idaho claims are almost contiguous with Rude Creek, within 600 meters.

The metallogeny in the Dawson Range is dominated by porphyry and mesothermal vein deposits. Idaho Creek lies 14 km east of the Casino porphyry gold-copper-molybdenum deposit. The Coffee gold project is located further to the northwest of Idaho Creek while gold-silver veins that hosted the former Mt. Nansen mine and Rockhaven Resources' Klaza Project are situated to the southeast. The Idaho Property sits within the Klotassin Batholith. It is bounded to the west by the northeast-trending Dip Creek Fault and to the north by a southeast-trending fault that is inferred to be the northerly extension of the Big Creek Fault. The Big Creek Fault typically exhibits two or more sub parallel structures that are the bounding faults of a two to eight kilometre wide graben. A belt of precious metal bearing veins and porphyry copper-gold prospects, associated with Cretaceous age, subvolcanic quartz-feldspar porphyry intrusions, extends southeasterly from the Coffee project for 120 km along the Big Creek Fault.

The metal signature of the soil geochemical anomalies and the stockwork fracture zones noticed in limited drilling when combined with the good geological setting are indicative of a high level porphyry setting perhaps quite similar to the Casino deposit 12 km to the northwest in conjunction with the Orogenic Gold potential.

Idaho Creek Mineralization

Previous grid soil geochemistry undertaken at the Idaho Property outlined anomalous gold, silver, lead, arsenic and zinc soil values in four main targets across the property, all apparently associated with one or both of two main structural trends related to the Big Creek Fault. The anomalous areas are up to 1,200 by 600 m in size and produced soil geochemical values ranging up to 6,550 ppb Au, 122 ppm Ag, 6,180 ppm Pb, 2,620 ppm As, 2,300 ppm Zn and 1,110 ppm Sb. The average silver to lead ratio for the samples is a particularity encouraging 366 grams /tonne silver per 1% lead.

A total of nine bulldozer trenches with a combined length of 2,398 m were excavated within the main soil geochemical anomalies in the 1980s. The trenches mostly bottomed in frozen soil and exposed only small patches of bedrock. Three types of mineralization identified in trenches or in outcrops include: disseminated sulphides in quartz diorite; chalcedony-calcite veins in limonitic quartz-feldspar porphyry; and sulphide-bearing manganiferous quartz veins.

Exploration renewed in 2006, consisting of 17-line km of induced polarization (IP) surveys and 556 m of reverse circulation drilling. Five percussion drill holes tested beneath float occurrences and soil geochemical anomalies in the western and central part of the property. Collar locations were based solely upon prospecting and geochemical data because IP results were not available prior to drilling. Anomalous gold and silver values were encountered in most holes. The results from holes ID-06-03 and -05, which tested downdip from geochemical anomalies that overly the main IP target, are particularly interesting. ID-06-03 is near a narrow, moderate chargeability anomaly that appears to be near the top of the main anomaly. It encountered two mineralized intervals, with the first returning 0.608 g/t gold and 20.6 g/t silver across 6.10 m starting at 9.14 m and the second yielding 0.551 g/t gold, 32.6 g/t silver, 0.46 % lead and 1.53 % zinc across 3.05 m starting at 73.15 m. ID-06-05 produced two 3.05 m intervals grading 0.33 g/t gold with 70.1 g/t silver and 0.092 g/t gold with 52.3 g/t silver. These intervals were cut from 36.58 and 60.96 m, respectively. None of the holes were drilled deep enough to test the main IP anomalies. In 2006, ATAC staked the Idaho claims, optioned them to Klondike Silver, and conducted an exploration program consisting of geophysical surveys and 556 m of reverse circulation (RC) drilling. The drill results returned an Au-Ag-Pb-Zn metal signature indicative of a high-level porphyry system (Wengzynowski, 2007).

In 2007, 1,118.42 m of diamond drilling was completed in four holes. All four holes intersected elevated gold, silver, lead, zinc associated with steeply dipping structures possibly above a buried porphyry system. The abundance of elevated gold-in-soil remains enigmatic (Smith, 2008).

In 2013, the Geological Survey of Canada completed a 1:100,000 scale regional map around the nearby Casino Cu-Mo-Au porphyry (Minfile 115J 028). During this work, a Casino suite aged porphyritic plug was mapped on the Idaho Creek property (Ryan et al., 2013).

In 2015, a helicopter-borne magnetic and radiometric survey was completed by Precision GeoSurveys over the Idaho Property. The survey revealed a 1000 x 500 m coincident total magnetic intensity high and potassium, uranium and thorium high in the south-west corner of the property.

Cautionary Statement

The potential quantity and grade of mineralization described herein is conceptual in nature as there has been insufficient exploration to define a mineral resource and it is uncertain if further exploration will result in the target being delineated as a mineral resource.

Qualified Person

Technical information in this news release has been approved by Grant Hendrickson, P.Geo. and ‘Qualified Person' as defined under Canadian National Instrument 43-101 Standards of Disclosure for Mineral Projects.

About the Company

Makara Mining Corp. (CSE:MAKA)(FSE:MK0)(OTC PINK:MAKAF) is a mineral exploration company focused on the acquisition, exploration and development of gold properties. The Company is based in Vancouver, B.C. and holds options over the Rude Creek Property and Idaho Creek Property located in the Yukon and the Kenora Gold Property located in Northwestern Ontario. Additional information about the Company is available at www.makaramining.com.

ON BEHALF OF THE BOARD OF DIRECTORS

Grant Hendrickson
Director and Chief Executive Officer
Telephone: 604-372-3707
Email: grant@makaramining.com

Forward-Looking Statements

This news release contains certain forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, and statements respecting the Company's anticipated exploration program at Rude Creek and the Option at Idaho Creek are "forward-looking statements". Forward-looking statements are subject to a number of risks and uncertainties, including those detailed from time to time in filings made by the Company with securities regulatory authorities, which may cause actual outcomes to differ materially from those discussed in the forward-looking statements. These factors should be considered carefully and readers are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements and information contained in this news release are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

SOURCE: Makara Mining Corp.

ReleaseID: 602322

– A provisional patent for the novel DNA aptamer and saliva Covid-19 test kit has been lodged

– Codenamed "Gumnuts", the test is extremely low cost, convenient and easy to use, significantly cheaper than current RNA and antigen-based test kits

– A world-class international team of scientist has been assembled for development and commercialisation

– Clinical trials will commence shortly, with a view to commercial availability before the end of 2020.

ZURICH / ACCESSWIRE / August 19, 2020 / Achiko AG (SIX:ACHI, ISIN CH0522213468) is pleased to announce progress with a non-intrusive and affordable novel Covid-19 test kit, codenamed "Gumnuts". With the assistance from Australian intellectual property firm FB Rice (Melbourne), developer Regenacellx.sl ("RCX") has filed a provisional patent over the technology. Achiko holds the exclusive commercialisation rights in exchange for a royalty and technical advice.

The Company has assembled a world-class internationally recognised team for the development and commercialisation of Gumnuts. The team is led by Dr Michael J. Edel (Chief Scientist) and Dr Thomas Pouplin, joined by Dr Jittaporn Wattanaseree and Dr Joalin Lim. Additionally, a larger science and commercialisation organisation that spans across Spain, Switzerland, Thailand, Singapore and Indonesia supports the team.

The planned Gumnuts kit is assembled around DNA aptamers and gold nanoparticles, combined with a saliva sample, and is proceeding to clinical trials shortly.

"After a significant number of years, projects and papers on nanoparticle bio-conjugation, we are now engaging studies on nanoparticle-aptamer bioconjugates for detection and actuation. What appeals in aptamers to us is their chemical robustness. This eases their industrial production while facilitating their use, as they offer longer shelf-life, tolerance to environmental changes and more stable performance in different media", said Dr Victor Pentes, ICREA Research Professor, Institució Catalana de Recerca i Estudis Avançats, VHIR and ICN2, Barcelona.

The first of many diagnostics planned to use the technology, Gumnuts is designed to be affordable and convenient. It delivers results in minutes and the testing experience is comparable to brushing one's teeth. Sold alone or combined with Achiko's pandemic management platform Teman Sehat ("Health Buddy"), the Company believes that the technology play a crucial role in resolving the world's problem with the pandemic.

Gumnuts has several differentiators and advantages over PCR, RT-PCR, LAMP, antigen and antibody test kits, all of which are currently being used globally. Current testing approaches may be constrained by reagents (supply chain, shelf life, etc.) or the required equipment (PCR/RT-PCR machines, trained technicians, etc.). They are confined in practical use (e.g. time to results, invasiveness, etc.) and suffer from accuracy issues (e.g. antigen tests) or high cost due to their structure. In contrast, DNA aptamers are known to be comparatively stable and may have a shelf life of more than a year at room temperature. The prospective materials required by Gumnuts may cost less than USD 1.00, dropping to only be a few cents when mass-produced. This opens up a realm of possibility for embedding testing in day-to-day applications beyond the approaches known to date.

"The Covid-19 pandemic has had an enormous impact around the world. To respond effectively, a precise and fast diagnosis is needed. The current testing technologies around PCR, antigen, and antibody test have problems such as the high cost of PCR tests and the time it takes to deliver results. Antibody tests miss the infection cycle and there are design weaknesses and reliability problems with antigen testing," said Dr Abdullah Qayyum, Epidemiologist, Riau Hospital Supervisory Agency, Indonesia. "Low cost and effective testing are key elements in responding to the pandemic. Research in alternative methods is needed now. We are excited to be involved in this project doing research and testing."

Clinical trials are set to begin shortly. If the trials prove successful, large-scale production of the test kit will begin with a view to commercial availability before the end of 2020. Currently, the Company is selecting manufacturers as well as distribution partners. It is also continuing development at a wider range of assay approaches for Covid-19.

"Our novel test kit is a comprehensive offering for government and industry, seeking solutions to manage their economies, sporting events, travel, education, etc. We're excited about and encouraged by the progress with vaccines. However, the Company believes that testing will be an issue for many years to come," says Steven Goh, CEO and Director of Achiko. "Along with Teman Sehat, our suite of solutions may allow governments and businesses to move to a broader proactive testing approach covering nearly the entire population."

Beyond the initial application of DNA aptamers to the Covid-19 pandemic and an array of assay formats (electronic, lateral, etc.), the Company is looking towards diagnostics for dengue, tuberculosis, cancer biomarkers and numerous other pathogens and believes that in combination with Teman Sehat, the technology may form the foundation of a diagnostics-as-a-service and telehealth business.

About Achiko AG

Headquartered in Switzerland, with a global market focus, Achiko AG (ISIN CH0522213468) is an entrepreneurial platform company, utilising the knowledge and experience of its people and key technologies to enable transformation in various industries.

Through innovations in technology and regulation along with the company's unique operating footprint from Europe to Asia, Achiko seeks to transform markets and bring unique value to its customers, people, and shareholders. Achiko's core platform consists of user registration and payment services which are accessible to application developers. A messaging service and other community based social features are being launched in late 2020. Achiko supports innovations in healthcare through its Teman Sehat ("Health Buddy") ecosystem, a novel testing technology being developed with Regenacellx.sl, as well as consumer payments and finance and games and entertainment.

For any inquiries regarding Teman Sehat or Gumnuts, please contact info@achiko.com

Further information about Achiko AG can be found at https://www.achiko.com

Further information about the Teman Sehat ecosystem can be found at https://www.temansehat.co

Further information about Regenacellx.sl can be found at https://regenacellx.com

For further Information about the research and development team:

– Dr Michael J. Edel, chief scientist ( https://regenacellx.com )

– Dr Jittaporn Wattanaseree ( http://www.thaitect.org/committee/Jittaporn_EN.pdf )

– Dr Thomas Pouplin ( https://www.tropmedres.ac/team/thomas-pouplin )

– Dr Joalin Lim, ( https://www.agape-lifess.com/ )

– Prof. Dr Víctor F. Puntes, ( http://www.inorganicnanoparticles.net/about/victor-puntes/ )

– Dr Abdullah Qayyum ( https://www.linkedin.com/in/dr-abdullah-qayyum-091aa475 )

Investor Relations & Press Contacts:

Achiko AG
Investor Relations
E: ir@achiko.com

Switzerland
Marcus Balogh
Farner Consulting Ltd.
E: achiko@farner.ch
T: +41 44 266 67 67

Germany and Austria
Axel Mühlhaus / Dr Sönke Knop
edicto GmbH
E: achiko@edicto.de
T: +49 69 90 55 05-51

Disclaimer
This communication expressly or implicitly contains certain forward-looking statements concerning Achiko AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Achiko AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Achiko AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

SOURCE: Achiko AG via EQS Newswire

ReleaseID: 602357

NEW YORK, NY / ACCESSWIRE / August 19, 2020 / Hundreds of millions of people all over the world are stuck in the corporate rat race. While some thrive in employment, many entrepreneurial people operate on a nine-to-five cycle that makes them dread their future. That was how William Beaird felt at his corporate job.

After a leap of faith, biting the bullet and succeeding past expectations, William is now on a mission to help those who feel there is more to life than their cubicle on the fifteenth floor of the 19th-century building on Parks Avenue.

William is an entrepreneur who has turned his mishaps into miracles through hard work and determination. He is the founder of Millennial to Millionaire and CEO of Hooked on Funnels, two educational businesses that help employees to build a profitable hustle that will help them escape the corporate highway. The entrepreneur has turned his business into an empire that generates up to six digits in profits and gives him the life he has always dreamed of.

And while William has seen tremendous success today, the process was brutal. After college, William did what most people do: he got a job. While he learned a lot from his managerial role and picked up a lot of value from his experience, he always felt that employment was only a stepping stone to his higher calling in life. William knew he was meant for something greater.

William mustered all the courage that he could and stepped out of his comfort zone. He quit his corporate job and began working on building his business. William's most significant challenges proved to be ahead of him still as he would, later on, face bankruptcy and homelessness. He ended up sleeping on a friend's office floor as he started to build ventures in Forex, dropshipping, and network marketing. He looked to influences that would earn six to seven digits of income through their businesses.

Little by little, William's sacrifices started to pay off as his business ventures slowly took flight. What started as side hustles would, later on, turn into six-figure businesses. Today, William has taken on a new challenge: to help those who were like him years ago, stuck in the hamster wheel of regrets and fears. William started Hooked on Funnels, a program that helps people start online businesses that use marketing funnels to sell products and services for high ticket. He also created Millennial to Millionaire, a content creation company that builds systems that will help millennials build successful online businesses.

William is a believer in the power of entrepreneurship to shape the future, and his primary goal is to build an army of digital business owners. They earn up to seven figures a month and radically impact the lives of others. The serial entrepreneur has his sights set on bigger goals as he aims to consistently earn seven figures a month and build his net worth to $300 million through real estate, stocks, commodities, and YouTube channels.

The online business mogul hopes that his story from homelessness to entrepreneurial success will inspire many others. William has made it his mission to guide those who believe they are fit to become employers and business owners in the pursuit of their dreams.

Company: Hooked On Funnels
Email: info@hookedonfunnels.com

Phone: 615-747-1628
Website: Get.HookedonFunnels.com

SOURCE: Hooked On Funnels

ReleaseID: 602374

New Inventory of Pharmaceutical-Grade Hand Sanitizer Now Available

VANCOUVER, BC / ACCESSWIRE / August 19, 2020 /  Ovation Science Inc. (CSE:OVAT) ("Ovation" or the "Company") announces that it has expanded its production of its DermSafe® Hand Sanitizer Lotion by completing the manufacturing of its first order in Canada at a contract manufacturer in Ontario that follows strict cGMP guidelines set by Health Canada.

Additionally, the Company is pleased to announce that it is now working with 5 distributors across Canada, with a strong focus on industries that can benefit from the use of DermSafe, including schools, independent retailers, sports facilities and private airlines amongst others.

"We having been successful manufacturing DermSafe through our existing channels in the USA however expanding our capacity to our Canadian contract manufacturer will improve availability and reduce delivery costs for our customers. We are pleased to have this additional source of inventory to supplement our current supply as we expand our reach across Canada and continue to meet the needs of the growing market," said Mr. Terry Howlett, President of Ovation. "People are purchasing DermSafe because they want an alternative to the drying effects of alcohol-based hand sanitizers. They also want to not only stay protected themselves but also to help employees feel more comfortable coming back to work or for students going back to school or university." He added, "There are two sizes of DermSafe available, a 59ml personal sized bottle which is easy to carry in your pocket or purse, as well as a commercial use 236ml bottle with a precise pump that can sit on a counter at home or at the office."

Facts About DermSafe Hand Sanitizer That Makes It Different:

DermSafe is listed by Health Canada as an approved product under: "Disinfectants and hand sanitizers accepted under COVID-19 interim measure."
DermSafe has two Drug Identification Numbers (DIN) for personal use and personal commercial use.
DermSafe has received the "Dermatology Seal of Approval" from the Canadian Dermatology Review Panel.
DermSafe is a pharmaceutical-grade hand sanitizer lotion backed by science.
It is made without alcohol therefore it is non-drying. Instead DermSafe offers the persistent protection of chlorhexidine gluconate; an ingredient used worldwide as a pre-surgical soap due to its proven abilities to kill germs.
DermSafe uses a proprietary polymer delivery system called Invisicare®, which enhances how products stay on the skin and how it delivers drugs to the skin.

Statements have not been evaluated by Health Canada. These products are not intended to diagnose, treat, cure, or prevent any disease.

For information about DermSafe and to purchase visit: https://dermsafe.com

For information about Ovation Science products visit: https://ovationscience.com/products/.

About Ovation Science Inc.

Ovation Science Inc. is a research and development company that develops topical and transdermal consumer products including DermSafe, all made with patented Invisicare® skin delivery technology. The technology enhances the delivery of ingredients to and through the skin and is protected by patents in eleven countries. With over twenty years of topical and transdermal drug delivery experience in the pharmaceutical market, Ovation's management and science team have created a unique pipeline of over twenty-five patent-protected medical / wellness topical and transdermal products along with a line of anti-aging / beauty formulas. Ovation earns revenues from licensing and development fees, royalties, the sale of Invisicare to its licensees and now revenue from its own product sales. Ovation has offices in Vancouver, BC Canada and Las Vegas, Nevada, USA. Ovation trades on the CSE under the symbol OVAT. Visit our website www.ovationscience.com.

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In particular there is no assurance of sales online or through distributors. There are no guarantees of future performance. Ovation Science Inc. cautions that all forward looking statements are inherently uncertain and that actual results may be affected by a number of material factors, many of which are beyond Ovation Science Inc.'s control. Accordingly, readers should not place undue reliance on the forward-looking information. Ovation disclaims any obligation to revise or update any such forward-looking information to reflect future results, events or circumstances, except as required by law.

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Contact:

INVESTOR RELATIONS:
Sebastian Kunyz: ovat@kincommunications.com Phone: 604-684-6730 or Toll Free at 866-684-6730

FOR BUSINESS DEVELOPMENT & CORPORATE INQUIRIES:
Doreen McMorran: doreen@ovationscience.com Phone: 604-283-0903 ext. 4

SOURCE: Ovation Science Inc.

ReleaseID: 602327

TORONTO, ONTARIO / ACCESSWIRE / August 19, 2020 / GlobeX Data Ltd. (OTCQB:SWISF)(CSE:SWIS) (“GlobeX” or the “Company”), the leader in Swiss hosted cyber security and Internet privacy solutions for secure data management and secure communications, is pleased to announce that it has rebranded DigitalSafe, its data security, collaboration suite, password management and secure email security solution, as part of its new push for its Sekur brand of privacy and security solutions. The new brand is to be called SekurSafe and replaces DigitalSafe. SekurSafe will retain all the functions of the old DigitalSafe, including the SekurMail encrypted email solution with real time archiving, data loss prevention, anti-phishing and anti-BEC attack technology called SekurSend. GlobeX has already rebranded its website and is launching the new website for SekurSafe in August 2020. The service will be accessible both from the SekurSafe and the Sekur websites. 

Alain Ghiai, CEO of GlobeX Data said: "As part of our Sekur brand launch, we have decided to complete all our branding efforts before the end of the summer, as we are expecting an increase in activity from all our distributors worldwide and this was a good time to complete the branding effort we have embarked on. SekurSafe is also going to benefit from some enterprise features we are planning to add this year. SekurSafe is part of a bigger effort to launch our Sekur brand which is being launched this month as well. DigitalSafe was the last of our three brands to be unified under the Sekur suite of privacy and security solutions and we are very happy to report that the transition to SekurSafe branding has been smooth and we expect the new website to be launched in the next few days. We had to act fast, in order to complete the transition before our emerging market distributors restart their activity, as business is slowly returning after the lock downs imposed by the COVID-19 global pandemic. We are also excited to be announcing the newest distributor of SekurSafe in the coming days, as soon as we get the all clear from the distributor to make the announcement. This distributor is a household name in over 100 countries and is a publicly traded company on the NYSE.” 

GlobeX Data has been working on a new security suite called Sekur and SekurSafe is part of that suite of secure data management and secure communications solutions. The solutions are all being launched in August 2020 and replace the previous brands GlobeX Data has had since inception. The solutions are as follows: 

SekurSafe, secure document management and sharing, collaboration, password management and secure email. 

Sekur, secure email, secure file share and secure messaging solution. 

SekurMail, secure email with SekurSend anti-phishing technology. 

SekurMessenger, secure messenger and file share. 

BEC attacks and email phishing attacks have increased exponentially in the last few months and the unprecedented situation of the COVID-19 pandemic has put global businesses under pressure to provide secure remote business management tools for their employees. This has created an increased awareness for secure cloud business services such as SekurSafe and Sekur, with its encrypted email service SekurMail. According to a study called sponsored by IBM called Cost of Data Breach 2020 the average cost of a data breach is US$3.86 million.  

GlobeX’s Data privacy solutions are all hosted in Switzerland, protecting users’ data from any outside data intrusion requests. In Switzerland, the right to privacy is guaranteed in article 13 of the Swiss Federal Constitution. The Federal Act on Data Protection (“FADP”) of 19 June 1992 (in force since 1993) has set up a strict protection of privacy by prohibiting virtually any processing of personal data which is not expressly authorized by the data subjects. The protection is subject to the authority of the Federal Data Protection and Information Commissioner. 

Under Swiss federal law, it is a crime to publish information based on leaked “secret official discussions.” In 2010 the Federal Supreme Court of Switzerland found that IP addresses are personal information and that under Swiss privacy laws they may not be used to track Internet usage without the knowledge of the individuals involved. 
 
About GlobeX Data Ltd. 
GlobeX Data Ltd. is a Cybersecurity and Internet privacy provider of Swiss hosted solutions for secure data management and secure communications. The Company distributes a suite of secure cloud-based storage, disaster recovery, document management, encrypted e-mails, and secure communication tools. GlobeX Data Ltd. sells its products through its approved wholesalers and distributors, and telecommunications companies worldwide. GlobeX Data Ltd. serves consumers, businesses and governments worldwide. 
 
On behalf of Management 

GLOBEX DATA LTD. 

Alain Ghiai 
President and Chief Executive Officer 
+1.416.644.8690 
corporate@globexdatagroup.com  

For more information please contact GlobeX Data at corporate@globexdatagroup.com or visit us at https://globexdatagroup.com.  
 
For more information on Sekur visit us at: https://www.sekur.com  
For more information on SekurSafe visit us at: https://www.sekursafe.com  

Forward Looking Information 
This news release contains certain forward-looking information within the meaning of applicable Canadian securities laws ("forward-looking statements"). All statements other than statements of present or historical fact are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "anticipate", "achieve", "could", "believe", "plan", "intend", "objective", "continuous", "ongoing", "estimate", "outlook", "expect", "project" and similar words, including negatives thereof, suggesting future outcomes or that certain events or conditions "may" or "will" occur. These statements are only predictions. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guaranteeing future performance. GlobeX cautions that all forward-looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond GlobeX’s control. Such factors include, among other things: risks and uncertainties relating to the future of the Company’s business; the success of marketing and sales efforts of the Company; the projections prepared in house and projections delivered by channel partners; the Company’s ability to complete the necessary software updates; increases in sales as a result of investments software development technology; consumer interest in the Products; future sales plans and strategies; reliance on large channel partners and expectations of renewals to ongoing agreements with these partners; anticipated events and trends; the economy and other future conditions; and other risks and uncertainties, including those described in GlobeX’s prospectus dated May 8, 2019 filed with the Canadian Securities Administrators and available on www.sedar.com. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, GlobeX undertakes no obligation to publicly update or revise forward-looking information. 

SOURCE: GlobeX Data Ltd.

ReleaseID: 602366